-$0.83 (-1.45%) As of 12:13 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome.

Stanley C. Erck
Gaithersburg, Maryland

NVAX Key Statistics

Market cap
Price-Earnings ratio
Dividend yield
Average volume
High today
Low today
Open price
52 Week high
52 Week low


ReutersJul 1

Novavax expects COVID vaccine targeting Omicron in fourth quarter

July 1 (Reuters) - Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development of
BloombergJun 29

Bull Market Never Ended for Analysts Wedded to 100% Price Rally Calls

(Bloomberg) -- Whether it’s commendable courage or a refusal to face reality, a receding stock market tide has left Wall Street analysts sitting with price pred
MarketWatchJun 29

Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized

Novavax’s NVAX, +0.96% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about how best to update the COVID-19 boosters to bet

NVAX Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
per share
Expected Aug 8, After Hours

More NVAX News

ReutersJun 29

Taiwan to receive first doses of Novavax COVID vaccine this week - Reuters

Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure